Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|August 16, 2016
Cart2Core® - Aseptic Cart Transferring System
Advertisement
Veltek Assocaites, Inc. has developed an innovative, patent pending, product that nearly eliminates the problematic issue of correct aseptic cart transference. Current industry practice for cleaning and disinfection of the upper portions of the cart, while labor intensive, are manageable. However, cleaning of bases, wheels, casters, and underneath the cart are virtually impossible, can cause numerous problems, and complicate worker safety.
The Cart2Core®, Aseptic Cart Transferring System, provides the ability for cleanroom operations to transfer materials through classified areas while reducing the possibility of cross-contamination. A previously arduous process has become simple. The cart top is able to be transferred to another previously cleaned cart base located in the next classified area. Simply lift the handle and slide the top of the cart onto the next base, leaving the potential contamination behind.
Available cart configurations include: a Micro Cart for production, micro, and cleaning personnel, a Can and Bottle Cart designed to convey large cans and bottles, and a Tray Cart for transporting trays of vials, parts, and other needed items. All carts are autoclavable, sterilizable, chemical resistant, have the capability to be RFID coded, and are constructed of 316L Stainless Steel.
Contact Details :
Veltek Associates, Inc.
Website:
E-mail: vai@sterile.com
Advertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Advertisement
Advertisement